4.8 Article

Stereodivergent atom-transfer radical cyclization by engineered cytochromes P450

Journal

SCIENCE
Volume 374, Issue 6575, Pages 1612-+

Publisher

AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.abk1603

Keywords

-

Funding

  1. University of California Santa Barbara
  2. National Institutes of Health [R35GM128779]
  3. NSF [DMR-1933487]

Ask authors/readers for more resources

Naturally occurring enzymes can be evolved to generate efficient biocatalysts for unnatural reactions. By repurposing cytochromes P450, stereoselective atom-transfer radical cyclization can be catalyzed, allowing for enantio- and diastereodivergent radical catalysis with substantial stereocontrol. This evolvable metalloenzyme platform offers a promising solution for asymmetric catalysis involving fleeting radical intermediates.
Naturally occurring enzymes can be a source of unnatural reactivity that can be molded by directed evolution to generate efficient biocatalysts with valuable activities. Owing to the lack of exploitable stereocontrol elements in synthetic systems, steering the absolute and relative stereochemistry of free-radical processes is notoriously difficult in asymmetric catalysis. Inspired by the innate redox properties of first-row transition-metal cofactors, we repurposed cytochromes P450 to catalyze stereoselective atom-transfer radical cyclization. A set of metalloenzymes was engineered to impose substantial stereocontrol over the radical addition step and the halogen rebound step in these unnatural processes, allowing enantio- and diastereodivergent radical catalysis. This evolvable metalloenzyme platform represents a promising solution to tame fleeting radical intermediates for asymmetric catalysis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available